ATRA
Price
$9.23
Change
+$0.81 (+9.62%)
Updated
Jun 6 closing price
Capitalization
50.55M
FULC
Price
$7.25
Change
+$0.14 (+1.97%)
Updated
Jun 6 closing price
Capitalization
383.52M
59 days until earnings call
Interact to see
Advertisement

ATRA vs FULC

Header iconATRA vs FULC Comparison
Open Charts ATRA vs FULCBanner chart's image
Atara Biotherapeutics
Price$9.23
Change+$0.81 (+9.62%)
Volume$93.31K
Capitalization50.55M
Fulcrum Therapeutics
Price$7.25
Change+$0.14 (+1.97%)
Volume$388.35K
Capitalization383.52M
ATRA vs FULC Comparison Chart
Loading...
ATRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATRA vs. FULC commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRA is a Buy and FULC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (ATRA: $7.80 vs. FULC: $6.90)
Brand notoriety: ATRA and FULC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATRA: 86% vs. FULC: 178%
Market capitalization -- ATRA: $50.55M vs. FULC: $383.52M
ATRA [@Biotechnology] is valued at $50.55M. FULC’s [@Biotechnology] market capitalization is $383.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATRA’s FA Score shows that 0 FA rating(s) are green whileFULC’s FA Score has 1 green FA rating(s).

  • ATRA’s FA Score: 0 green, 5 red.
  • FULC’s FA Score: 1 green, 4 red.
According to our system of comparison, FULC is a better buy in the long-term than ATRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATRA’s TA Score shows that 8 TA indicator(s) are bullish while FULC’s TA Score has 3 bullish TA indicator(s).

  • ATRA’s TA Score: 8 bullish, 2 bearish.
  • FULC’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ATRA is a better buy in the short-term than FULC.

Price Growth

ATRA (@Biotechnology) experienced а +12.97% price change this week, while FULC (@Biotechnology) price change was +10.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

FULC is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FULC($384M) has a higher market cap than ATRA($50.6M). FULC YTD gains are higher at: 46.809 vs. ATRA (-41.435). FULC has higher annual earnings (EBITDA): -18.24M vs. ATRA (-75.75M). FULC has more cash in the bank: 241M vs. ATRA (42.5M). FULC has less debt than ATRA: FULC (8.63M) vs ATRA (43.8M). ATRA has higher revenues than FULC: ATRA (129M) vs FULC (80M).
ATRAFULCATRA / FULC
Capitalization50.6M384M13%
EBITDA-75.75M-18.24M415%
Gain YTD-41.43546.809-89%
P/E RatioN/AN/A-
Revenue129M80M161%
Total Cash42.5M241M18%
Total Debt43.8M8.63M508%
FUNDAMENTALS RATINGS
ATRA vs FULC: Fundamental Ratings
ATRA
FULC
OUTLOOK RATING
1..100
1925
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
27
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10092
PRICE GROWTH RATING
1..100
3435
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FULC's Valuation (27) in the null industry is somewhat better than the same rating for ATRA (75) in the Biotechnology industry. This means that FULC’s stock grew somewhat faster than ATRA’s over the last 12 months.

FULC's Profit vs Risk Rating (100) in the null industry is in the same range as ATRA (100) in the Biotechnology industry. This means that FULC’s stock grew similarly to ATRA’s over the last 12 months.

FULC's SMR Rating (92) in the null industry is in the same range as ATRA (100) in the Biotechnology industry. This means that FULC’s stock grew similarly to ATRA’s over the last 12 months.

ATRA's Price Growth Rating (34) in the Biotechnology industry is in the same range as FULC (35) in the null industry. This means that ATRA’s stock grew similarly to FULC’s over the last 12 months.

ATRA's P/E Growth Rating (100) in the Biotechnology industry is in the same range as FULC (100) in the null industry. This means that ATRA’s stock grew similarly to FULC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATRAFULC
RSI
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 12 days ago
85%
Bearish Trend 12 days ago
85%
Momentum
ODDS (%)
Bullish Trend 12 days ago
80%
N/A
MACD
ODDS (%)
Bullish Trend 12 days ago
87%
Bearish Trend 12 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
82%
Bullish Trend 12 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
80%
Bullish Trend 12 days ago
87%
Advances
ODDS (%)
Bullish Trend 12 days ago
83%
Bullish Trend 21 days ago
86%
Declines
ODDS (%)
Bearish Trend 28 days ago
87%
Bearish Trend 18 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
90%
Bearish Trend 12 days ago
87%
Aroon
ODDS (%)
Bullish Trend 12 days ago
72%
Bullish Trend 12 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ATRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

ATRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRA has been loosely correlated with AMLX. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRA jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRA
1D Price
Change %
ATRA100%
+4.07%
AMLX - ATRA
65%
Loosely correlated
+1.48%
GRI - ATRA
40%
Loosely correlated
+3.05%
SLRX - ATRA
39%
Loosely correlated
-4.17%
NTLA - ATRA
36%
Loosely correlated
+3.59%
FULC - ATRA
35%
Loosely correlated
+8.66%
More

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with ANNX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then ANNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
+8.66%
ANNX - FULC
40%
Loosely correlated
+3.05%
VRDN - FULC
40%
Loosely correlated
-3.09%
RARE - FULC
39%
Loosely correlated
-2.08%
BMRN - FULC
38%
Loosely correlated
-0.03%
PTGX - FULC
37%
Loosely correlated
-1.46%
More